CN1172641A - 紫外线吸收性组合物 - Google Patents
紫外线吸收性组合物 Download PDFInfo
- Publication number
- CN1172641A CN1172641A CN97110939A CN97110939A CN1172641A CN 1172641 A CN1172641 A CN 1172641A CN 97110939 A CN97110939 A CN 97110939A CN 97110939 A CN97110939 A CN 97110939A CN 1172641 A CN1172641 A CN 1172641A
- Authority
- CN
- China
- Prior art keywords
- acid
- ester
- oil
- poe
- ultraviolet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 150000005690 diesters Chemical class 0.000 claims abstract description 27
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 33
- HIPQTCQUXOFTFI-UHFFFAOYSA-N 2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)C(=O)C1=CC=CC=C1 HIPQTCQUXOFTFI-UHFFFAOYSA-N 0.000 claims description 21
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 claims description 8
- 229940031578 diisopropyl adipate Drugs 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 239000007788 liquid Substances 0.000 abstract description 5
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- -1 polyol fatty acid ester Chemical class 0.000 description 83
- 239000003921 oil Substances 0.000 description 51
- 235000019198 oils Nutrition 0.000 description 51
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 45
- 235000014113 dietary fatty acids Nutrition 0.000 description 25
- 239000000839 emulsion Substances 0.000 description 25
- 239000000194 fatty acid Substances 0.000 description 25
- 229930195729 fatty acid Natural products 0.000 description 25
- 150000002148 esters Chemical class 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 16
- 230000032683 aging Effects 0.000 description 14
- 238000002425 crystallisation Methods 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 206010009866 Cold sweat Diseases 0.000 description 13
- 239000002250 absorbent Substances 0.000 description 12
- 230000002745 absorbent Effects 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- 230000008025 crystallization Effects 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000005342 ion exchange Methods 0.000 description 9
- 229920002521 macromolecule Polymers 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 8
- 235000013599 spices Nutrition 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 7
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 6
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229930182817 methionine Natural products 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- 229940031439 squalene Drugs 0.000 description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000000265 homogenisation Methods 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- 229960001860 salicylate Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 244000050427 Melilotus officinalis subsp suaveolens Species 0.000 description 3
- 235000000839 Melilotus officinalis subsp suaveolens Nutrition 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 235000012677 beetroot red Nutrition 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- 235000002185 betanin Nutrition 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000007766 cera flava Substances 0.000 description 3
- 238000005660 chlorination reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 3
- 239000011863 silicon-based powder Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- JHHXPQAUADQJBQ-UHFFFAOYSA-N 5,5-dimethylcyclohepta-1,3,6-triene-1-carboxylic acid Chemical compound CC1(C)C=CC=C(C(O)=O)C=C1 JHHXPQAUADQJBQ-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 2
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- LOZPMZAYDOOUPL-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)CC(C1=CC=CC=C1)=O.[O] Chemical compound C(C1=CC=CC=C1)(=O)CC(C1=CC=CC=C1)=O.[O] LOZPMZAYDOOUPL-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 244000147568 Laurus nobilis Species 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 2
- 244000173166 Pyrus ussuriensis Species 0.000 description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- BNOODXBBXFZASF-UHFFFAOYSA-N [Na].[S] Chemical compound [Na].[S] BNOODXBBXFZASF-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- CLPHAYNBNTVRDI-UHFFFAOYSA-N ditert-butyl propanedioate Chemical compound CC(C)(C)OC(=O)CC(=O)OC(C)(C)C CLPHAYNBNTVRDI-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- ARJXIGOIOGJAKR-LURJTMIESA-N ethyl L-methioninate Chemical compound CCOC(=O)[C@@H](N)CCSC ARJXIGOIOGJAKR-LURJTMIESA-N 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229910052901 montmorillonite Inorganic materials 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000012177 spermaceti Substances 0.000 description 2
- 229940084106 spermaceti Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- KIZCNUWGIVQQBK-UHFFFAOYSA-N (2-hydroxy-4-methylphenyl)-phenylmethanone Chemical compound OC1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 KIZCNUWGIVQQBK-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- QLSANCGSHSPSDS-FJSYBICCSA-N (2s)-2-(octadecanoylamino)pentanedioic acid;sodium Chemical compound [Na].[Na].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O QLSANCGSHSPSDS-FJSYBICCSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 1
- LZTJZRSWZOSPFQ-UHFFFAOYSA-N 2-(3,4-dihydroxy-1-phenylbutylidene)-4-ethyl-3-oxooctanoic acid Chemical compound C(C(O)CO)C(=C(C(=O)O)C(C(CCCC)CC)=O)C1=CC=CC=C1 LZTJZRSWZOSPFQ-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- APWRLAZEMYLHKZ-UHFFFAOYSA-N 2-amino-5,6-dimethyl-1h-pyrimidin-4-one Chemical compound CC=1NC(N)=NC(=O)C=1C APWRLAZEMYLHKZ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- BOZWETCMSXFTOW-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;16-methylheptadecanoic acid Chemical class CCC(CO)(CO)CO.CC(C)CCCCCCCCCCCCCCC(O)=O BOZWETCMSXFTOW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical class OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- AXJXRLHTQQONQR-UHFFFAOYSA-N 3-benzoylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 AXJXRLHTQQONQR-UHFFFAOYSA-N 0.000 description 1
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 1
- DMICIZVPSKKBDO-UHFFFAOYSA-N 3-methylidenepiperidine Chemical class C=C1CCCNC1 DMICIZVPSKKBDO-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- NPFYZDNDJHZQKY-UHFFFAOYSA-N 4-Hydroxybenzophenone Chemical class C1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 NPFYZDNDJHZQKY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 102100035475 Blood vessel epicardial substance Human genes 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- QLYHVLWJJRLFJQ-UHFFFAOYSA-N CCC(CCCCC)(CC)P(O)(O)=O.OCC Chemical compound CCC(CCCCC)(CC)P(O)(O)=O.OCC QLYHVLWJJRLFJQ-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001094636 Homo sapiens Blood vessel epicardial substance Proteins 0.000 description 1
- 101000608194 Homo sapiens Pyrin domain-containing protein 1 Proteins 0.000 description 1
- 101000595404 Homo sapiens Ribonucleases P/MRP protein subunit POP1 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000124079 Mylabris Species 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical class CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- JNVXSSIIICQSJH-UHFFFAOYSA-N S(=O)(=O)(O)C(C(=O)O)CC(=O)O.C(CCCCC)[Na] Chemical class S(=O)(=O)(O)C(C(=O)O)CC(=O)O.C(CCCCC)[Na] JNVXSSIIICQSJH-UHFFFAOYSA-N 0.000 description 1
- PHIIYDSPMYGDAF-UHFFFAOYSA-N S(=O)(=O)(O)O.C(CCCCCCCCCCC)[K] Chemical compound S(=O)(=O)(O)O.C(CCCCCCCCCCC)[K] PHIIYDSPMYGDAF-UHFFFAOYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical group CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NUXFDCYXMLVOFU-AYBRVATOSA-N [(1S,2R,3R,4S,5R,6S,8R,9S,10S,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-acetamidobenzoate Chemical compound CCN1C[C@]2(COC(=O)c3ccccc3NC(C)=O)CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@](O)([C@@H](OC)[C@H]23)[C@@H]14 NUXFDCYXMLVOFU-AYBRVATOSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- LWXKMYSEIONCLB-UHFFFAOYSA-J [Na+].[Na+].[Na+].[Na+].CCC(CCCCC)(CC)P([O-])([O-])=O.OCC.CCC(CCCCC)(CC)P([O-])([O-])=O Chemical compound [Na+].[Na+].[Na+].[Na+].CCC(CCCCC)(CC)P([O-])([O-])=O.OCC.CCC(CCCCC)(CC)P([O-])([O-])=O LWXKMYSEIONCLB-UHFFFAOYSA-J 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960003513 batilol Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- LPTWEDZIPSKWDG-UHFFFAOYSA-N benzenesulfonic acid;dodecane Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCCCCCCCCCCC LPTWEDZIPSKWDG-UHFFFAOYSA-N 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- BKXRKRANFLFTFU-UHFFFAOYSA-N bis(prop-2-enyl) oxalate Chemical compound C=CCOC(=O)C(=O)OCC=C BKXRKRANFLFTFU-UHFFFAOYSA-N 0.000 description 1
- 150000001638 boron Chemical class 0.000 description 1
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CRMOQBWCUTZBKJ-UHFFFAOYSA-N chloromethyl-methyl-dioctadecylazanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(CCl)CCCCCCCCCCCCCCCCCC CRMOQBWCUTZBKJ-UHFFFAOYSA-N 0.000 description 1
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 229960000729 cyclandelate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229950003988 decil Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- OUWSNHWQZPEFEX-UHFFFAOYSA-N diethyl glutarate Chemical compound CCOC(=O)CCCC(=O)OCC OUWSNHWQZPEFEX-UHFFFAOYSA-N 0.000 description 1
- PEUGOJXLBSIJQS-UHFFFAOYSA-N diethyl octanedioate Chemical compound CCOC(=O)CCCCCCC(=O)OCC PEUGOJXLBSIJQS-UHFFFAOYSA-N 0.000 description 1
- 229940031768 diglycol stearate Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- PEJVLWCOQVHCAF-UHFFFAOYSA-N dioctyl oxalate Chemical compound CCCCCCCCOC(=O)C(=O)OCCCCCCCC PEJVLWCOQVHCAF-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- MVKYQTGCKJXECD-UHFFFAOYSA-N ethane-1,2-diol;prop-1-ene Chemical compound CC=C.CC=C.OCCO MVKYQTGCKJXECD-UHFFFAOYSA-N 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical group CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical group COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical group COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- XTPZUZXXXZKNGH-UHFFFAOYSA-N nonanoic acid pentanamide Chemical compound C(CCCC)(=O)N.C(CCCCCCCC)(=O)O XTPZUZXXXZKNGH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229950002083 octabenzone Drugs 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- QXVUGSHEKWUGTL-UHFFFAOYSA-N octyl 2-methoxy-3-phenylprop-2-enoate Chemical class CCCCCCCCOC(=O)C(OC)=CC1=CC=CC=C1 QXVUGSHEKWUGTL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NFIYTPYOYDDLGO-UHFFFAOYSA-N phosphoric acid;sodium Chemical compound [Na].OP(O)(O)=O NFIYTPYOYDDLGO-UHFFFAOYSA-N 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- LUPNKHXLFSSUGS-UHFFFAOYSA-M sodium;2,2-dichloroacetate Chemical compound [Na+].[O-]C(=O)C(Cl)Cl LUPNKHXLFSSUGS-UHFFFAOYSA-M 0.000 description 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 description 1
- CIZOCKPOEXXEHB-UHFFFAOYSA-N tetradecan-3-ol Chemical compound CCCCCCCCCCCC(O)CC CIZOCKPOEXXEHB-UHFFFAOYSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- HFUMBCROCNBYQL-UHFFFAOYSA-N trimethyl(octadecanoyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC(=O)[N+](C)(C)C HFUMBCROCNBYQL-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- CBKXFKIKYXQCCE-UHFFFAOYSA-K trisodium 1-octadecoxyoctadecane phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC CBKXFKIKYXQCCE-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 150000003732 xanthenes Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
Abstract
本发明的紫外线吸收组合物,含有下述成分(A)和(B)为特征:(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷,(B)具有以下述通式(1)表示的结构而且在20℃是液状的二酯,R1OOC-(CH2)n-COOR2 (1) (式中,R1和R2是碳原子数1—19的烷基、链烯基、羟烷基或羟链烯基,n是0—6的整数)。根据本发明,通过同时使用(B)的二酯,抑制难溶性的UV-A吸收剂(A)的结晶析出,能够得到在组合物中能高浓度且稳定地配合(A)而且使用感和安全性均优良的紫外线吸收性组合物。
Description
本发明是关于紫外线吸收性组合物,特别是关于改进配合有难溶性UV-A吸收剂4-叔丁基-4′-甲氧二苯甲酰基甲烷的组合物的时效稳定性、使用感等。
太阳光中包含的紫外线,在皮肤科学上分为400nm-320nm的长波紫外线(UV-A)、320nm-280nm的中波紫外线(UV-B)、280nm以下的短波紫外线。其中290nm以下波长的紫外线被臭氧层吸收,不到达地表。
到达地表的UA-A和UV-B范围的紫外线对人的皮肤产生种种影响。到达地上的紫外线中,UV-B形成皮肤红斑和水泡,还促进黑素形成。而UV-A引起皮肤的褐色化,促进皮肤的弹性降低和发生皱纹,或者对某种患者增强此种反应,甚至进而能成为光毒性或光变应性反应的原因。为了保护皮肤免受这种紫外线的有毒性,已开发了各种紫外线吸收剂。
其中,作为吸收较长波长的UV-A的物质,4-叔丁基-4′-甲氧二苯甲酰基甲烷正引起人们的注意。但是,该4-叔丁基-4′-甲氧二苯甲酰基甲烷是难溶于水和油的固体,与化妆料和皮肤外用剂基剂的相溶性差,随时间变化析出4-叔丁基-4′-甲氧二苯甲酰基甲烷的结晶。为了解决像这样的问题,进行了各种研究。例如,已提出:与4-叔丁基-4′-甲氧二苯甲酰基甲烷一起配合液状的多元醇脂肪酸酯(特开昭61-215315),配合C9-31醇与C9-31酸的酯(特开昭61-215316),配合碘价70以上的油(特开昭61-215317)等。
但是,配合了上述物质的化妆料和皮肤外用剂存在油性感和发粘的问题。另外,因为高浓度地配合4-叔丁基-4′-甲氧二苯甲酰基甲烷,如果配合多量的液状多元醇脂肪酸酯,由此产生痒和辣乎乎感等刺激。
本发明就是鉴于这样的以往技术问题而完成的,其目的在于提供在组合物中高浓度地配合难溶性UV-A吸收剂4-叔丁基-4′-甲氧二苯甲酰基甲烷时也能稳定地配合、而且无油性感和发粘感、具有爽快的使用感、且安全性高的紫外性防御效果良好的组合物。
为了达到上述的目的,发明人进行了深入研究,结果发现,如果4-叔丁基-4′-甲氧二苯甲酰基甲烷与特定的二酯同时使用,在组合物中就能稳定地配合4-叔丁基-4′-甲氧二苯甲酰基甲烷,得到使用感和安全性良好的紫外线吸收性组合物,从而完成了本发明。
即,本发明的紫外线吸收性组合物的特征是,含有下述的成分(A)和(B)。
(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷。
(B)具有以下述通式(1)表示的结构、且在20℃是液状的二酯。
R1OOC-(CH2)n-COOR2 (1)
(式中,R1和R2是碳原子数1-19的烷基、链烯基、羟烷基或羟链烯基,n表示0-6的整数)。
实施例
本发明中使用的上述成分(A)为4-叔丁基-4′-甲氧二苯甲酰基甲烷,例如可以将按照特开昭55-66535中记载的方法制造,另外,作为市售品可以使用例如赋形药(Volso1)1789(ジボタン公司制)等。4-叔丁基-4′-甲氧二苯甲酰基甲烷是在约330-360nm具有最大吸收的良好UV-A吸收剂,其配合量根据所期待的紫外线吸收效果而适当选择,不作特别限制,但在组合物全量中通常是0.1-20%(重量),最好是0.1-10%(重量)。过少量不到足够的紫外线吸收效果,另外,如果是化妆料和皮肤外用剂,配合20%(重量)也得到充分的效果。
另外,本发明的另一必须成分(B)的二酯,是以上述通式(1)表示的饱和二羧酸的二酯,而且在20℃是液状。在通式(1)中,R1和R2表示相同或不同、碳原子数1-19的烷基、链烯基、羟烷基或羟基链烯基,但R1和R2是相同基者,容易得到和制造,是优选的。另外,这些基可以是直链状、支链状,环状中的任一种。R1和R2优选的是碳原子数1-8的烷基,尤其最好是碳原子数4-8的烷基。
另外,n表示0-6的整数,但较好是2-4的整数,尤其最好是2或4。
在上述通式(1)中,R1和R2的碳原子数及n值过大时,该组合物产生油性感和发粘,因而是不理想的。另外,二酯在20℃是固体或半固体的情况下,从该组合物的使用感和经时稳定性的观点看都是不理想的。
本发明中使用的二酯是公知物质,可以使用市售品,当然也可以使用公知的反应来制造。例如HOOC-(CH2)n-COOH(n是0-6的整数)表示的饱和二羧酸或其酸酐作原料,可利用公知的酯化反应来制造。
在本发明中使用的二酯的具体例子,可举出草酸二辛酯、丙二酸二甲酯、丙二酸二乙酯、丙二酸二丁酯、丙二酸二(2-乙基己)酯、琥珀酸二乙酯、琥珀酸二己酯、琥珀酸二异丙酯、琥珀酸二辛酯、或戊二酸二乙酯、己二酸二丙酯、己二酸二异丙酯、己二酸二异丁酯、辛二酸二乙酯、草酸二烯丙酯、丙二酸二(2-羟基己)酯、丙二酸二(4-羟基-1-丁)酯等。再者,作为本发明的二酯,可以使用它们之中的一种或二种以上。
上述的二酯之中,较好是琥珀酸二辛酯、己二酸二异丙酯,尤其最好是琥珀酸二辛酯。琥珀酸二辛酯是无色无臭的液体。己二酸二异丙酯虽然是无色液体,但多量配合,有感觉到微弱的臭气的问题。
(A)的4-叔丁基-4′-甲氧二苯甲酰基甲烷,依赖于其配合量发挥高的紫外线吸收效果,但因为对化妆料和皮肤外用剂的基剂的相溶性差,所以越高量配合,在组合物中越容易析出结晶。
根据本发明,通过将上述(B)的二酯与(A)同时配合在该组合物中,可以解决像这样的问题,同时得到其使用感和安全性均良好的紫外吸收性组合物。(B)对(A)的这样的效果在上述以往技术中无任何记载,而由本发明人初次发现。
在有关本发明的紫外线吸收性组合物中,为了将(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷稳定地配合在该组合中,组合物中的(B)二酯的配合量,相对组合物中的(A)的配合量是1/3倍量(重量)为宜。该二酯即使在本发明的组合物中过剩配合,也不妨碍本发明的效果。相对本发明的该组合物,二酯的配合量不作特别限制,但通常是0.01-50%(重量),最好是0.5-20%(重量)的范围。过多就产生油分多。
另外,例如像乳化组合物那样,在油相比例不到100%的场合,要想在组合物中配合一定量的(A),油相比例越小,油相中的(A)浓度就必须越高。本发明中使用的二酯以少量使用能够抑制(A)的结晶析出,而且在油相中即使多量配合也不产生发粘和刺激感,因此在像这样的乳化组合物中,在高量配合(A)的场合也是非常有用的。例如,即使在油相中的(A)浓度是5%(重量)以上的高浓度配合的场合,相对油相中的(A)浓度,油相中的(B)二酯的浓度形成1/3倍(重量%)以上的配合,能够抑制(A)的结晶析出,而且能够形成使用感和安全性均良好的组合物。
如上所述,本发明的组合物,能够发挥高的UV-A吸收效果,而且在使用感、稳定性和安全性方面也优良,作为为了保护皮肤或毛发不受紫外线侵害而使用的酸性保护组合物是非常有用的。
本发明的紫外线吸收性组合物可用常规的方法制造,只要是能发挥本发明的效果,其剂型就不作特别限定。例如,除洗剂、乳液、乳油、油等基础化妆料之外,可举出粉底、口红、面红、眼影、アイブロウ等调制化妆料,头发花样剂、头发处理剂、头发洗剂、头发液体剂等头发化妆料。再者,它们根据需要,可以制成壳状和粘附状、喷雾、泥、带辊等种种形态。另外,本发明的紫外线吸收性组合物也可以适合用作药用化妆料或药用组合物等。
在本发明的化妆料中,除上述必须成分之外,还可以配合在通常的化妆料和皮肤外用剂中使用的成分,例如表面活性剂、水溶性介质、油性成分、高级醇、天然及合成高分子、金属离子封锁剂、水溶性及油溶性聚合物、无机及有机颜料、无机有机粘土矿物质、经金属抑处理或硅处理的无机和有机颜料、有机染料等色料、防腐剂、防氧化剂、色素、增粘剂、pH调整剂、香料、紫外线吸收剂、保湿剂、血液循环促进剂、冷感剂、制冷剂、杀菌剂、皮肤赋活剂等可以在不损害本发是的目的和效果的质和量的范围内配合。
例如,亲油性非离子表面活性剂可举出脱水山梨糖醇一油酸酯、脱水山梨糖醇一异硬脂酸酯、脱水山梨糖醇一月桂酸酯、脱水山梨糖醇一棕榈酸酯、脱水山梨糖醇一硬脂酸酯、脱水山梨糖醇倍半油酸酯、脱水山梨糖醇三油酸酯、五一2-乙基己酸双甘油脱水山梨糖醇酯、四-2-乙基己酸双甘油脱水山梨糖醇酯等脱水山梨脂肪酸酯类,一棉籽油脂肪酸甘油酯、一芥酸甘油酯、倍半油酸甘油酯、一硬脂酸甘油酯、二异硬脂酸甘油酯、α,α′-油酸焦谷氨酸甘油酯、一硬脂酸甘油酯苹果酸等聚甘油脂肪酸甘油酯类,一硬脂酸丙二醇酯等脂肪酸丙二醇酯类,硬化蓖麻油衍生物,甘油烷基醚等。
亲水性非离子表面活性剂例如可举出POE脱水山梨糖醇一油酸酯、POE脱水山梨糖醇一硬脂酸酯、POE脱水山梨糖醇四油酸酯等POE脱水山梨糖醇脂肪酸酯类,POE山梨糖醇一月桂酸酯、POE山梨糖醇一油酸酯、POE山梨糖醇五油酸酯、POE山梨糖醇一硬脂酸酯等POE山梨糖醇脂肪酸酯类,POE一硬脂酸酯、POE二硬脂酸酯、二硬脂酸乙二醇酯等POE脂肪酸酯类,POE月桂基醚、POE油醚、POE硬脂醚、POE山嵛醚、POE-2-辛基月桂基醚、POE胆甾烷醇醚等POE烷基醚类,POE辛苯基醚、POE壬苯基醚、POE二壬苯基醚等POE烷苯基醚类。普路罗尼克(プルロニツク)等普路罗尼克型表面活性剂类,POE·POP鲸蜡醚、POE·POP丁基醚、POE·POP2-癸基十四烷基醚、POE·POP一丁基醚、POE·POP氢化羊毛脂等POE·POP烷基醚类,テトロニツケ等四POE·四POP1,2-乙二胺缩合物类,POE蓖麻油、POE硬化蓖麻油,POE硬化蓖麻油一异脂酸酯、POE硬化蓖麻油三异硬脂酸酯、POE硬化蓖麻油一焦谷氨酸二酯、POE硬化蓖麻油马来酸等POE蓖麻油衍生物,POE山梨糖醇蜂蜡等POE蜂蜡·羊毛脂衍生物,椰子油脂肪酸二乙醇酰胺、月桂酸一乙醇酰胺、脂肪酸异丙醇酰胺等烷醇酰胺,POE脂肪酸酰胺,蔗糖脂肪酸酯,POE壬基苯基甲醛缩合物,烷基乙氧基二甲胺氧化物,三油基磷酸等。
另外,阳离子表面活性剂例如可举出肥皂用坯料,月桂酸钠、棕榈酸钠、硬脂酸钠等脂肪酸皂,月桂基硫酸钠、月桂基硫酸钾等高级烷基硫酸酯盐,POE月桂基硫酸三乙醇胺、POE月桂基硫酸钠等烷基醚硫酸酯盐,月桂酰肌氨酸钠等N-酰基肌氨酸,N-十四烷酰-N-甲基牛磺酸钠、椰子油脂肪酸甲基牛磺钠、月桂基甲基牛磺钠等高级脂肪酸氨基磺酸盐,POE油醚磷酸钠、POE硬脂醚磷酸钠等磷酸酯盐,二2-乙己基磺基琥珀酸钠、一月桂醚一乙醇酰胺聚氧乙烯磺基琥珀酸钠等磺基琥珀酸盐,直链月桂基苯磺酸钠、直链月桂基苯磺酸三乙醇胺、直链月桂基苯磺酸等烷基苯磺酸盐,N-月桂酰谷氨酸-钠、N-硬脂酰谷氨酸二钠、N-十四烷-L-谷氨酸-钠等N-酰基谷氨酸盐,硬化蓖麻油脂肪酸甘油硫酸钠等高级脂肪酸酯硫酸盐,磺化油等硫化油,POE烷基醚羧酸,POE烷基醚羧酸盐,α-链烯磺酸盐,高级脂肪酸烷基醇酰胺硫酸酯盐,月桂酰一乙醇酰胺琥珀钠,N-棕榈酰天冬氨酸双三乙醇胺,酪蛋白钠等。
阳离子表面活性剂例如可举出氯化硬脂酰三甲基铵氯化月桂基三甲基铵等烷基三甲基铵盐,氯化二硬脂基二甲基铵等二烷基二甲基铵盐,氯化聚(N,N-二甲基-3,5-亚甲基哌啶鎓)、氯化十六烷基吡啶鎓等烷基吡啶鎓盐,烷基季铵盐,烷基二甲苄基铵盐,烷基异喹啉鎓盐,二烷基硼鎓盐,POE烷胺,烷胺盐,多胺脂肪酸衍生物,戊醇脂肪酸衍生物,氯化苄烷铵,苄索氯铵等。
两性表面活性剂例如可举出2-十一烷基-N,N,N-(羟乙基羧甲基)-2-咪唑啉钠、2-可可基-2-咪唑啉鎓羟基化物-1-羧基乙羟氧基二钠盐等咪唑啉系两性表面活性剂,2-十七烷基-N-羧甲基-N-羟乙基咪唑啉鎓甜菜碱、月桂基二甲胺乙酸甜菜碱、烷基甜菜碱、酰胺甜菜碱、磺基甜菜碱等甜菜碱系表面活性剂等。
这些表面活性剂可以一种或二种以上组合使用,对配合量不作特别限定,但形成乳化组合物时,在全组成中配合0.01-20%(重量)为宜。不到0.01%(重量),不能得到稳定的乳浊液,超过20%(重量),使用感恶化。
另外,水性介质可以单独使用水,或者水和下述物质并用,这些物质可举出乙醇、甘油、聚乙二醇、丙二醇、二丙二醇、1,3-丁二醇、木糖醇、山梨糖醇、多糖醇、硫酸软骨素、透明质酸、硫酸粘多糖、卡洛宁酸、亚油酸胶原、胆甾基-12-羟基硬脂酸盐、乳酸钠、胆汗酸盐、d1-吡咯烷酮羧酸盐、短链可溶性胶原、双甘油(EO)PO加合物、イザヨイバラ提取液、セイヨウノコギリソウ提取液、草木樨提取液等。这些水溶性介质的配合量不加特别限制,但在作为乳化组合物的场合,在全组成中配合0.1-40%(重量),最好是2-30%(重量)。在不到0.1%(重量)时,感觉恶化,超过40%(重量),得不到稳定的乳浊液。
另外,油性成分可举出如下那样的物质。作为液体油脂有鳄梨油、山茶子油、海龟油、澳洲坚果油、玉米油、水貂油、橄榄油、菜子油、卵黄油、芝麻油、杏仁油、小麦胚芽油、山茶花油、蓖麻油、亚麻仁油、红花油、棉籽油、紫苏子油、大豆油、花生油、茶子油、椰子油、米糠油、桐油、日本桐油、霍霍巴油、胚芽油、三甘油、三辛酸甘油酯、四辛酸季戊四醇酯、三异棕榈酸甘油酯等。
固体油脂有可可脂、椰子油、硬化椰子油、棕榈油、棕榈仁油、木蜡油、硬化油、木蜡、硬化蓖麻油等。
蜡类有蜂蜡、小烛树蜡、棉蜡、巴西棕榈蜡、月桂子蜡、虫蜡、鲸蜡、褐煤蜡、米糠蜡、羊毛脂、木棉蜡、乙酸羊毛脂、液状羊毛脂、甘蔗蜡、羊毛脂肪酸异丙酯、月桂酸己酯、还原羊毛脂、希蒙德木蜡、硬质羊毛脂、虫胶蜡、POE羊毛脂醇醚、POE羊毛脂醇乙酸酯、POE担甾醇醚、羊毛脂脂肪酸聚乙二醇、POE氢化羊毛脂醇醚等。
烃油有液体石蜡、地蜡、角鲨烯、姥鲛烷、石蜡、纯地蜡、角鲨烯、凡士林、微晶蜡等。
合成酯油有肉豆蔻酸异丙酯、辛酸十六烷基酯、肉豆蔻酸辛基月桂在酯、棕榈酸异丙酯、硬脂酸丁酯、月桂酸己酯、肉豆蔻酸十四烷基酯、油酸癸酯、二甲基辛酸己基月桂基酯、乳酸十六烷基酯、乳酸肉豆蔻酯、乙酸羊毛脂、硬脂酸异十六烷基酯、异硬脂酸异十六烷基醌、12-羟基硬脂酸胆甾基酯、二2-乙基己酸乙二醇酯、二季戊四醇脂肪酸酯、一异硬脂酸N-烷基二醇酯、二癸酸新戊二醇酯、草酸二异硬脂酰酯、二2-庚基十一酸甘油酯、三2-乙基己酸三羟甲基丙烷、三异硬脂酸三羟甲基丙烷、四2-乙基己酸季戊四醇酯、三2-乙基己酸甘油酯、棕榈酸(2-乙基己)酯、三肉豆蔻酸甘油酯、三2-庚基十一酸甘油酯、蓖麻油脂肪酸甲酯、油酸油烯酯、乙酰甘油、棕榈酸(2-庚基癸)酯、月桂酰-L-谷氨酸(2-辛基十二烷基)酯、月桂酸乙酯、癸二酸二(2-乙基己)酯、肉豆蔻酸(2-己基癸)酯、棕榈酸(2-己基癸)酯、己二酸-(2-己基癸)酯、癸二酸二异丙酯、琥珀酸-(2-乙基己)酯、乙酸乙酯、乙酸丁酯、乙酸或酯、棕檬酸三乙酯等。
硅氧烷有例如二甲基聚硅氧烷、甲苯基聚硅氧烷、甲基氢化二烯聚硅氧烷等链状聚硅氧烷,八甲基环四硅氧烷、十四甲基环五硅氧烷、十二甲基环六硅氧烷等环状硅氧烷等。
这些油性成分的配合量不加特别限制,但在作为乳化组合物的场合,在全组成中配合0.5-60%(重量),最好2.5-40%(重量)。
高级醇可例如举出月桂醇、鲸蜡醇、硬脂醇、山俞醇、肉豆蔻醇、油醇、十八醇十六醇混合物等直链醇,一硬脂甘油醚(鲨肝醇)、2-癸基十四烷醇、羊毛脂醇、胆甾醇、植物甾醇、乙基十二烷醇、异硬脂酰醇、辛基十二烷醇等支链醇等。
金属离子封闭剂例如可举出1-羟基乙烷-1,1-二膦酸、1-羟基乙烷-1,1-二膦酸四钠盐、依地酸二钠、依地酸三钠、依地酸四钠、柠檬酸钠、多磷酸钠、甲基磷酸钠、葡糖酸、磷酸、柠檬酸、抗坏血酸、琥珀酸、依地酸等。
天然的水溶性高分子例如可举出阿拉伯树胶、而黄蓍胶、半乳糖、愈疮胶、角豆树胶、刺梧桐树胶、カラギ-ナン、果胶、琼脂、クインスシ-ド(木瓜)、アルグコロイド(カツソウエキス)、淀粉(米、玉米、马铃薯、小麦)、甘草酸等植物系高分子,占吨胶、葡萄糖、琥珀葡聚糖、ブルラン等微生物系高分子,胶原、酪蛋白、白蛋白、明胶等动物系高分子。
半合成的水溶性高分子例如可以举出:羧甲基淀粉、甲基羟丙基淀粉等淀粉系高分子,甲基纤维素、硝基纤维素、乙基纤维素、甲基羟丙基纤维素、羟乙基纤维素、纤维素硫酸钠、羟丙基纤维素、羧甲基纤维素钠(CMC)、结晶纤维素、纤维素末等纤维素系高分子,褐藻酸钠、海藻酸丙二醇酯等海藻酸系分子。
半合成的水溶性高分子例如可举出聚乙烯醇、聚乙烯基甲基醚、聚乙烯吡咯烷酮、聚羟乙烯聚合物(カ-ボポ-ル)等乙烯系高分子,聚乙二醇20000、6000、4000等聚氧乙烯系高分子,聚氧乙烯聚丙烷共聚物等共聚合系高分子,聚丙烯酸钠、聚乙基丙烯酸酯、聚丙烯酰胺等丙烯系高分子,聚乙烯亚胺,阳离子聚合物。
无机的水溶性高分子例如可举出膨润土、硅酸AlMg(ビ-ガム)、ラポナイト、锂蒙脱石、无水硅酸等。
紫外线吸收剂可举出对氨基苯甲酸(以下简称PABA)、PABA一甘油酯、N,N-二丙氧基PABA乙酯、N,N-二乙氧基PABA乙酯、N,N-二甲基PABA乙酯、N,N-二甲基PABA丁酯等苯甲酸系紫外线吸收剂,高盖基-N-乙酰氨茴酸酯等氨茴酸系紫外线吸收剂,戊基水杨酸酯、盖基水杨酸酯、高盖基水杨酸酯、辛基水杨酸酯、苯基水杨酸酯、苄基水杨酸酯、对异丙醇苯基水杨酸酯等水杨酸系紫外线吸收剂,辛基肉桂酸酯、乙基-4-异丙基内桂酸酯、甲基-2,5-二异丙基肉桂酸酯、乙基-2,4-二异丙基肉桂酸酯、甲基-2,4-二异丙基肉桂酸酯、丙基-对甲氧基肉桂酸酯、异丙基-对甲氧基肉桂酸酯、异戊基-对甲氧基肉桂酸酯、辛基-对甲氧基肉桂酸酯(2-乙己基-对甲氧基肉桂酸酯)、2-乙氧基乙基-对甲氧基肉桂酸酯、环己基-对甲氧基肉桂酸酯、乙基-α-氰基-β-苯基肉桂酸酯、2-乙己基-α-氰基-β-苯基肉桂酸酯、甘油基-2-乙基己酰-二对甲氧基肉桂酸酯等肉桂酸系紫外线吸收剂,2,4-二羟基二苯甲酮、2,2′-二羟基-4-甲氧基二苯甲酮、2,2′-二羟基-4,4′-二甲氧基二苯甲酮,2,2′,4,4′-四羟基二苯甲酮、2-羟基-4-甲基二苯甲酮、2-羟基-4甲氧基-4′-甲基二苯甲酮、2-、2-羟基-4-甲氧基二苯甲酮-5-磺酸盐、4-苯基二苯甲酮、2-乙己基-4′-苯基-二苯甲酮-2-羧酸盐、2-羟基-4-正辛氧基二苯甲酮、4-羟基-3-羧基二苯甲酮等二苯甲酮系紫外线吸收剂,3-(4′-甲亚苄基)-d,1-樟脑,3-亚苄基-d,1-樟脑,尿刊酸、尿刊酸乙酯,2-苯基-5-甲基苯并噁唑、2,2′-羟基-5-甲苯基苯并三唑、2-(2′-羟基-5′-叔丁苯基)苯并三唑、2-(2′-羟基-5′-甲苯基)苯并三唑,二亚苄基拉嗪(ジベンザラジン),二茴香酰甲烷,5-(3,3-二甲基-降五冰片基)-3-戊烷-2-酮等。
血液循环促进剂可举出壬酸戊酰胺、烟酸苄酯、烟酸β-丁氧基乙酯、辣椒素、姜油酮、斑蝥酊、鱼石脂、咖啡因、单宁酸、α-冰片、烟酸生育酚、烟酸肌醇酯、环扁桃酯、肉桂苯哌嗪、妥拉苏林、乙酰胆碱、异搏定、顶花防己碱、γ-谷维醇等药物,这些药物的游离的状态当然以能造盐的酸或碱式盐的形式使用,并且能酯化的也能以其酯的形式使用。
以下,作为本发明必须成分(B)的二酯示例地选择使用二己酸二丙酯、琥珀酸二辛酯,更详细地说明本发明。再者,除非以下特别指定,配合量以组合物中的重量%表示。
试验例1 时效稳定性和使用感
首先,按照下述表1的处方调制乳液。调制方法是将油相部的成分和水相部的成分分别加热到70℃、完全溶解后,使油相部混合到水相部中,用乳化机进行乳化处理。将得到的乳化组合物在热交换器中冷却到终温30℃,得到W/O型紫外线吸收性乳液。
按照下述方法对乳液评价时效稳定性、使用感。
时效稳定性
将各乳液放入容器中,在-5℃和0℃保存一个月,进行显微镜观察。评价基准如下。
经时稳定性评价基准
○…完全未看到4-叔丁基-4′-甲氧二苯甲酰基甲烷的结晶
△…稍微看到4-叔丁基-4′-甲氧二苯甲酰基甲烷的结晶
×…明显看到4-叔丁基-4′-甲氧二苯甲酰基甲烷的结晶
使用感
在10名女性评审成员的脸部和上腕部1日1次连续三周地涂布各乳液,对其使用感进行征询意是,按照下述评价基准进行评价。
使用感评价基准
○…评价为发粘感的评审员是2名以下
△…评价为发粘感的评审员是3名以上6名以下
×…评价为发粘感的评审员是7名以上
表1
试验例No.成分 1-1 1-2 1-3 1-4 1-5油相:己二酸二异丙酯 15.0 - - - -琥珀酸二辛酯 - 15.0 - - -三-2-乙基己酸 - - - - 15.0甘油酯四-2-乙基己酸 - - 15.0 10.0 -季戊四醇酯4-叔丁基-4′-甲 5.0 5.0 5.0 5.0 5.0氧二苯甲酰基甲烷硬脂醇 3.0 3.0 3.0 3.0 3.0辛基甲氧基肉 5.0 5.0 5.0 5.0 5.0桂酸酯硬脂酸 0.5 0.5 0.5 0.5 0.5山俞酸 0.5 0.5 0.5 0.5 0.5甘油一硬脂酸酯 1.0 1.0 1.0 1.0 1.0自乳化型POE(5)甘油一硬 1.0 1.0 1.0 1.0 1.0脂酸酯水相:羧酸乙烯聚合物 0.2 0.2 0.2 0.2 0.2三乙醇胺 0.4 0.4 0.4 0.4 0.4丙二醇 10.0 10.0 10.0 10.0 10.0乙醇 5.0 5.0 5.0 5.0 5.0对羟基苯甲酸甲酯 0.1 0.1 0.1 0.1 0.1依地酸三钠 0.1 0.1 0.1 0.1 0.1离子交换水 残余 残余 残余 残余 残余总量 100 100 100 100 100时效稳定性 ○ ○ △ × △(-5℃保存)时效稳定性 ○ ○ △ × △(0℃保存)使用感 ○ ○ × △ △
由表1可知,以往为了稳定地配合(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷而使用多元醇的脂肪酸酯(三-2-乙基己酸甘油酯或四-2-乙基己酸季戊四醇酯)的乳液(试验例1-3~1-5),在刚制造之后,(A)均匀地溶解,但在-5℃和0℃保存一个月后,看到(A)的结晶析出。(A)如果作为结晶析出,配合(A)的组合物的紫外线吸收就显著降低。另外,试验例1-3~1-5的乳液有发粘感,无令人满意的使用感。
与此相反,使用二酯(己二酸二异丙酯、琥珀酸二辛酯)的本发明乳液(试验例1-1~1-2),在-5℃和0℃保存一个月后也完全看不到(A)的结晶析出,该乳液是能够稳定地发挥所期望为紫外线吸收效果的乳液。另外,这些乳液由于使用二酯,无发粘感,有爽快的使用感,是可能高浓度地配合(A)的。另外,这些乳液也没有痒和火辣辣等刺激感。
由以上可认为本发明的紫外线吸收性组合物,在高浓度地配合4-叔丁基一4′-甲氧二苯甲酰基甲烷的场合,是时效稳定性良好、而且使用感和安全性优良的紫外线吸收性组合物。
试验例2 二酯的配合量
下面,在上述试验例1-1或试验例1-2的处方中,像下述表2和表3那样变化(B)二酯的配合量同样地调制乳液,调查(B)的配合量对时效稳定性的影响。再者,(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷的配合量在组合物中固定在6.0%(重量),以离子交换水调整(A)和(B)的变化量。
表2
试验例No.
成分 2-1 2-2 2-3 2-4己二酸二异丙酯 1.0 2.0 10.0 30.04-叔丁基-4′-甲 6.0 6.0 6.0 6.0氧二苯甲酰基甲烷时效稳定性 × ○ ○ ○(-5℃保存)时效稳定性 △ ○ ○ ○(0℃保存)
表3
试验例No.
成分 2-5 2-6 2-7 2-8琥珀酸二辛酯 1.0 2.0 10.0 30.04-叔丁基-4′-甲 6.0 6.0 6.0 6.0氧二苯甲酰基甲烷时效稳定性 × ○ ○ ○(-5℃保存)时效稳定性 △ ○ ○ ○(0℃保存)
从表2、3可知,相对于(A)的配合量,二酯的配合量(按重量)少于1/3倍量时,在-5℃和0℃保存一个月后,看到(A)的结晶析出。
由以上可知,在本发明的紫外线吸收性组合物中,相对于组合物中的(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷的配合量,组合物中的(B)二酯的配合量(按重量)是1/3倍量以上是合适的。
试验例3 在油相中的配合量
下面,用下表4中所示的油代替上述试验例1-1的油相,同样调制乳液,调查其时效稳定性和使用感。
表4
试验例No.
成分 3-1 3-2 3-3 3-4 3-5油相:琥珀酸二辛酯 - - - 2.0 5.0四-2-乙基己酸 2.0 5.0 2.0 - -季戊四醇酯4-叔丁基-4′-甲 0.8 1.0 0.5 0.8 1.0氧二苯甲酰基甲烷硬脂醇 3.0 3.0 3.0 3.0 3.0甲氧基肉桂酸辛酯 5.0 5.0 5.0 5.0 5.0硬脂酸 0.5 0.5 0.5 0.5 0.5山俞酸 0.5 0.5 0.5 0.5 0.5甘油一硬脂酸酯 1.0 1.0 1.0 1.0 1.0自乳化型POE(5)甘油一硬 1.0 1.0 1.0 1.0 1.0脂酸酯水相:羧酸乙烯聚合物 0.2 0.2 0.2 0.2 0.2三乙醇胺 0.4 0.4 0.4 0.4 0.4丙二醇 10.0 10.0 10.0 10.0 10.0甲醇 5.0 5.0 5.0 5.0 5.0对氧苯甲酸甲酯 0.1 0.1 0.1 0.1 0.1依地酸三钠 0.1 0.1 0.1 0.1 0.1离子交换水 残余 残余 残余 残余 残余总量 100 100 100 100 100(A)/油相×100(%) 5.8 5.9 3.7 5.8 5.9时效稳定性 △ ○ ○ ○ ○(-5℃保存)时效稳定性 △ ○ ○ ○ ○(0℃保存)使用感 ○ △ ○ ○ ○
由表4可知,在使用以往用的油分(四-2-乙基己酸季四戊醇酯)时,如果油相中的(A)浓度超过5%(重量)以上,就不能形成不产生发粘和结晶析出的组合物(试验例3-1~3-3)。
与此相反,如果使用本发明的(B)二酯(琥珀酸二辛酯),例如即使在油相中配合5%(重量)以上的(A),也不产生发粘感,而且能防止结晶析出(试验例3-4~3-5)。
因此,本发明对于油相中的(A)是低浓度的情况就不用说了,即使(A)是高浓度的情况也不产生发粘感,能抑制(A)的结晶析出,例如油相中的(A)浓度是5%(重量)以上时是特别有用的。
实施例1 W/O紫外线吸收性乳液
处方
油相:
棕榈酸 0.1
山萮酸 0.1
琥珀酸二己酯 6.0
棕榈酸辛酯 5.0
三-2-乙基己酸甘油酯 5.0
鲸蜡醇 1.0
硬脂醇 1.0
十四甲基环五硅氧烷 20.0
二对甲氧基肉桂酸2-~- 3.0
乙基己酸甘油酯
4-叔丁基-4′-甲氧 2.0
二苯甲酰基甲烷
聚氧乙烯·甲基聚 2.0
硅氧烷共聚物
一硬脂酸脱水山梨 0.5
糖醇酯
球状聚乙烯(10μ) 0.2
香料 0.1
水相:
乙醇 5.0
蛋氨酸 0.2
イザヨイバラ提取液 0.2
2-羟基-4-甲氧二苯甲 0.1
酮-5-磺酸钠
茴香提取物 0.1
二亚丙基乙二醇 2.0
氢氧化钾 0.2
离子交换水 残余
制造方法
油相部(除球状聚乙烯)和水相部分别在70℃加热进行溶解。使球状聚乙烯充分分散于油相中,边进行均匀化处理,边添加水相部。用热交换器冷却乳化物,得到W/O紫外线吸收性乳液。
实施例2 O/W紫外线吸收性遮阳光乳膏
处方
油相:
甲氧基肉桂酸辛酯 8.0
4-叔丁基-4′-甲氧二 8.0
苯甲酰基甲烷
四-2-乙基己酸季四 3.0
戊醇酯
2-羟基-4-甲氧二苯甲酮 3.0
琥珀酸二辛酯 24.0
微粒二氧化钛 7.0
角鲨烯 20.0
聚氧乙烯·甲基聚硅氧 3.0
烷共聚物
有机变形蒙脱石 1.5
硅粉末(5μ) 5.0
蛋氨酸 0.2
香料 0.1
γ-谷维醇 0.1水相:
达纳炸药用甘油 3.0
プラヤンタ提取物 0.1
依地酸三钠 0.2
离子交换水 残余
制造方法
水相部分加热到70℃进行溶解。除二氧化钛、硅粉末以外的成分,油相部分进行加热溶解后,使二氧化钛、硅粉末充分分散。一面进行均匀化处理,一面向水相部分添加油相部分,用热交换器冷却乳化物,得到O/W紫外线吸收性遮阳光乳膏。
实施例3 O/W紫外线吸收性乳脂
处方
油相:
二对甲氧基肉桂酸-~-2- 1.0
乙基己酸甘油酯
4-叔丁基-4′-甲氧 1.0
二苯甲酰基甲烷
2-羟基-4-甲氧二 1.0
苯甲酮
鲸蜡醇 1.0
己二酸二异丙酯 3.0
微粒二氧化钛 0.5
角鲨烯 20.0
凡士林 1.0
霍霍巴油 1.0 一硬脂酸甘油酯 3.0有机变形蒙脱石 1.5聚甲基丙烯酸酯(粒径8μ) 2.0蛋氨酸 0.2香料 0.1水相:达纳炸药用甘油 3.0草木樨提取液 0.5离子交换水 残余制造方法与实施例2相同,得到O/W紫外线吸收性乳膏。实施例4 O/W紫外线吸收性乳膏处方油相:硬脂酸 4.0硬脂醇 4.0甘油一硬脂酸酯 3.0维生素E乙酸酯 0.05香料 0.1蛋氨酸乙酯 0.1蛋氨酸丁酯 0.1丙二酸二乙酯 5.0甲氧基肉桂酸辛酯 1.04-叔丁基-4′-甲氧 1.0二苯甲酰基甲烷水相:1,3-丁二醇 3.0丙二醇 3.0甘油 2.0
氢氧化钾 0.4
离子交换水 残余
制造方法
在70℃加热水相部分,一面进行均匀化处理,一面加热添加已溶解的油相部分。用热交换器冷却乳化物,得到O/W紫外线吸收性乳膏。
实施例5 O/紫外线吸收性乳液
处方
油相:
角鲨烯 5.0
油酸油烯酯 3.0
甲苯基聚硅氧烷 1.0
凡士林 1.0
脱水山梨糖醇倍半油酸酯 0.8
聚氧乙烯(20)油醚 1.2
甲氧基肉桂酸辛酯 3.0
4-叔丁基-4′甲氧 5.0
二苯甲酰基甲烷
2-羟基-4-甲氧二苯甲酮 2.0
丙二酸二丁酯 15.0
香料 0.3水相:
二丙二醇 3.0
乙醇 5.0
羧甲基乙烯聚合物 0.2
透明质酸钠 0.01
氢氧化钾 0.08
蛋氨酸甲酯 0.15
六偏磷酸钠(试剂一级) 0.02
依地酸三钠 0.05
离子交换水 残余制造方法与实施例4同样进行,得到O/W紫外线吸收性乳液。实施例6 O/W紫外线吸收性香精处方油相:
硬脂酸 1.0
鲸蜡醇 1.3
羊毛脂衍生物 2.0
液体石蜡 2.0
琥珀酸二己酯 5.0
POE鲸蜡醇醚 1.0
一硬脂酸甘油酯 2.0
二对甲氧基肉桂酸~ 0.5
-2-乙基己酸甘油酯
4-叔丁基-4′-甲氧 1.5
二苯甲酰基甲烷
蛋氨酸丁酯 适量
蛋氨酸乙酯 适量水相:
1,3-丁二醇 6.0
2羟基-4-甲氧二苯 0.05
甲酮-5-磺酸钠
三乙醇胺 3.0
胎盘提取物 0.01
イザヨイバラ提取物 0.1
离子交换水 残余制造方法
与实施例4同样进行,得到O/W紫外线吸收性香精。
实施例7 W/O紫外线吸收性遮阳光乳膏
处方
油相:
琥珀酸二辛酯 40.0
甲氧基肉桂酸辛酯 7.0
4-叔丁基-4′-甲氧二苯 5.0
甲酰基甲烷
十四甲基环五硅氧烷 10.0
2-羟基-4-甲氧二苯甲酮 2.0
疏水化处理微粒氧化锌 5.0
疏水化处理二氧化钛 4.0
有机变形蒙脱石 2.0
防腐剂 0.3
香料 0.2水相:
1,3-丁二醇 6.0
依地酸三钠 0.2
离子交换水 残余
制造方法
除疏水化处理二氧化钛和疏水化处理微粒氧化锌外,油相部分成分在70℃加热溶解,使疏水化处理二氧化钛和疏水化处理微粒氧化锌充分分散。一面进行均匀化处理,一面向油相部分添加水相部分,用热交换器冷却乳化物,得到W/O紫外线吸收性遮阳光乳脂。
实施例8 W/O紫外线吸收性乳脂
处方
油相:
二对甲氧基肉桂酸-~-2- 1.0
乙基己酸甘油酯
4-叔丁基-4′-甲氧 1.0
二苯甲酰基甲烷
2-羟基-4-甲氧二苯甲酮 1.0
鲸蜡醇 1.0
微粒二氧化钛 0.5
角鲨烯 20.0
凡士林 1.0
己二酸二异丙酯 30.0
霍霍巴油 1.0
一硬脂酸甘油酯 3.0
硅酸铝镁 2.0
氯化二硬脂酰二甲基铵 1.0
蛋氨酸 0.2
香料 0.1
水相:
达纳炸药用甘油 3.0
草木樨提取液 0.5
离子交换水 残余
制造方法
与实施例7同样进行,得到W/O紫外线吸收性乳脂。
上述实施例1-8都是经时稳定性、使用感和安全性优良的、能发挥良好紫外线吸收效果的紫外线吸收性组合物。
如以上所说明,根据本发明,通过同时使用特定的二酯,即使高浓度地配合难溶性的UV-A吸收剂4-叔丁基-4′-甲氧二苯甲酰基甲烷,也能得到经时稳定性良好、无油性感和发粘感、具有爽快的使用感、而且无刺激性、安全性高的紫外线吸收性组合物。
Claims (8)
1、紫外线吸收性组合物,其特征是含有下述的成分(A)和(B):
(A)4-叔丁基-4′-甲氧二苯甲酰基甲烷,
(B)具有以下述通式(1)表示的结构,而且在20℃是液状的二酯,
R1OOC-(CH2)n-COOR2 (1)式中,R1和R2分别是碳原子数1-19的烷基、链烯基、羟烷基或羟链烯基,n是0-6的整数。
2、权利要求1所述的组合物,其特征是,组合物中的(B)的配合量相对于组合物中的(A)的配合量(重量)是1/3倍量以上。
3、权利要求1或2所述的组合物,其特征是油相中的(A)的浓度是5%(重量)以上,而且油相中的(B)的浓度,相对于油相中的(A)的浓度(重量%)是1/3倍以上。
4、权利要求1-3中任一项所述的组合物,其特征是,R1和R2是碳原子数1-8的烷基。
5、权利要求1-4中任一项所述的组合物,其特征是,n是2-4的整数。
6、权利要求1-5中任一项所述的组合物,其特征是,(B)是琥珀酸二辛酯。
7、权利要求1-5中任一项所述的组合物,其特征是,(B)是己二酸二异丙酯。
8、权利要求1-7中任一项所述的紫外线吸收性组合物的使用方法,其特征是,为了保护人的皮肤或毛发不受紫外线侵害,而用于皮肤或毛发。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP65400/96 | 1996-02-26 | ||
JP65400/1996 | 1996-02-26 | ||
JP6540096 | 1996-02-26 | ||
JP044596/1997 | 1997-02-12 | ||
JP044596/96 | 1997-02-12 | ||
JP04459697A JP3537622B2 (ja) | 1996-02-26 | 1997-02-12 | 紫外線吸収性組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1172641A true CN1172641A (zh) | 1998-02-11 |
CN1162144C CN1162144C (zh) | 2004-08-18 |
Family
ID=26384547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB971109397A Expired - Fee Related CN1162144C (zh) | 1996-02-26 | 1997-02-26 | 紫外线吸收性组合物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US5849272A (zh) |
EP (1) | EP0791353B1 (zh) |
JP (1) | JP3537622B2 (zh) |
KR (1) | KR100472671B1 (zh) |
CN (1) | CN1162144C (zh) |
AU (1) | AU706812B2 (zh) |
DE (1) | DE69723331T2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100393298C (zh) * | 2003-06-24 | 2008-06-11 | 巴斯福股份公司 | 由uv-a和uv-b过滤剂组成的混合物 |
CN102066904B (zh) * | 2008-06-13 | 2015-07-15 | 株式会社资生堂 | 皮肤代替膜、模具以及皮肤外用剂的评价方法 |
CN106999385A (zh) * | 2014-11-10 | 2017-08-01 | 花王株式会社 | 水包油型紫外线防护化妆品 |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2274110C (en) * | 1996-12-06 | 2002-08-13 | The Procter & Gamble Company | Hair conditioning compositions comprising water-insoluble high molecular weight oily compound |
JPH11152207A (ja) * | 1997-11-20 | 1999-06-08 | Shiseido Co Ltd | 化粧料 |
FR2765104B1 (fr) * | 1997-06-26 | 2000-05-05 | Jean Noel Thorel | Compositions cosmetiques et utilisations pour la protection contres les rayonnements uv-a et uv-b |
JP3211027B2 (ja) * | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
AU6106500A (en) * | 1999-07-15 | 2001-02-05 | Playtex Products, Inc. | Sunscreen aerosol composition |
JP4406855B2 (ja) * | 2000-03-17 | 2010-02-03 | 株式会社ビメーク | 化粧料 |
AU6312501A (en) * | 2000-05-23 | 2001-12-03 | Procter & Gamble | Skin care moisturizing and sunscreen compositions comprising organic particulatematerial |
US6878368B2 (en) * | 2001-03-29 | 2005-04-12 | San-Ei Kagaku Co., Ltd. | Composition for blending to hair treating agents and a hair treating agent |
US6835375B2 (en) * | 2001-03-30 | 2004-12-28 | San-Ei Kagaku Co., Ltd. | Composition for blending to hair treating agent and a hair treating agent |
JPWO2003015735A1 (ja) * | 2001-08-21 | 2004-12-02 | 協和発酵ケミカル株式会社 | 化粧料用油剤および化粧料 |
US6696048B2 (en) * | 2001-12-20 | 2004-02-24 | Schering-Plough Healthcare Products, Inc. | Sunscreen composition |
US7153494B2 (en) * | 2002-10-21 | 2006-12-26 | L'oreal | Dibenzoylmethane sunscreen compositions photostabilized with amphiphilic block copolymers |
US7163673B2 (en) * | 2003-06-17 | 2007-01-16 | The United States Of America As Represented By The Secretary Of Agriculture | Sunscreen reagents from hydroxy-substituted acylglycerides |
TWI337086B (en) * | 2003-09-03 | 2011-02-11 | Hisamitsu Pharmaceutical Co | Transdermal formulation containing nonsteroidal antiinflammatory drug |
JP4284147B2 (ja) * | 2003-10-10 | 2009-06-24 | 日清オイリオグループ株式会社 | 化粧料原料用紫外線防御製剤及び当該製剤を含有する化粧料の製造方法 |
TWI414320B (zh) * | 2004-05-13 | 2013-11-11 | Hisamitsu Pharmaceutical Co | 含有非類固醇系消炎鎮痛劑之外用經皮製劑 |
ES2590258T3 (es) * | 2004-06-15 | 2016-11-21 | Hisamitsu Pharmaceutical Co., Inc. | Preparación antiinflamatoria y analgésica para uso externo |
FR2886144B1 (fr) * | 2005-05-27 | 2007-06-29 | Oreal | Procede de photostabilisation d'un derive de dibenzoylmethane par un derive sulfone de merocyanine ; compositions cosmetiques photoprotectrices contenant cette associaton. |
CN101878021A (zh) * | 2007-11-28 | 2010-11-03 | 高露洁-棕榄公司 | 乙氧基化的和/或氢化的油加合物 |
MY153862A (en) * | 2007-11-28 | 2015-03-31 | Colgate Palmolive Co | Alpha or beta hydroxy acid adducts of oil |
JP4827877B2 (ja) * | 2008-03-31 | 2011-11-30 | 株式会社 資生堂 | 日焼け止め化粧料 |
JP2012523378A (ja) * | 2009-03-20 | 2012-10-04 | ザ プロクター アンド ギャンブル カンパニー | 油溶性固体日焼け止め剤を含むパーソナルケア組成物 |
DE102009045753A1 (de) * | 2009-10-16 | 2011-04-21 | Henkel Ag & Co. Kgaa | Sonnenschutzzusammensetzungen mit verbessertem Lichtschutzfaktor |
DE102009055919A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen enthaltend Kombinationen aus Zingeron und grenz- oder oberflächenaktiven Polyglycerylverbindungen |
DE102009055917A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Verwendung von Zingeron gegen Altershaut |
FR2971707B1 (fr) * | 2011-02-18 | 2013-02-15 | Oreal | Composition cosmetique aqueuse contenant des particules de materiau composite et du gamma-oryzanol |
FR2972346B1 (fr) * | 2011-03-09 | 2013-11-08 | Oreal | Utilisation d'un derive diester d'acide 2-methyl succinique comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant |
KR102239036B1 (ko) * | 2013-05-10 | 2021-04-13 | 바스프 에스이 | 다량의 uv 안정화제를 함유하는 작용제 |
JP6022405B2 (ja) * | 2013-05-29 | 2016-11-09 | 日本メナード化粧品株式会社 | 化粧料 |
ES2724483T3 (es) | 2014-02-27 | 2019-09-11 | Hisamitsu Pharmaceutical Co | Emplasto que contiene ketoprofeno |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH648753A5 (de) * | 1981-07-22 | 1985-04-15 | Givaudan & Cie Sa | Lichtschutzmittel. |
JPH064529B2 (ja) * | 1985-03-20 | 1994-01-19 | 株式会社資生堂 | 皮膚外用剤 |
JPH0645531B2 (ja) * | 1985-03-20 | 1994-06-15 | 株式会社資生堂 | 皮膚外用剤 |
JPH0645532B2 (ja) * | 1985-03-20 | 1994-06-15 | 株式会社資生堂 | 皮膚外用剤 |
JPH0645530B2 (ja) * | 1985-03-20 | 1994-06-15 | 株式会社資生堂 | 皮膚外用剤 |
JPS61215317A (ja) * | 1985-03-20 | 1986-09-25 | Shiseido Co Ltd | 皮膚外用剤 |
US4699779A (en) * | 1986-02-18 | 1987-10-13 | Victor Palinczar | Waterproof sunscreen compositions |
US4731242A (en) * | 1986-03-21 | 1988-03-15 | Victor Palinczar | Waterproof sunscreen compositions |
JP3190712B2 (ja) * | 1991-10-22 | 2001-07-23 | 株式会社資生堂 | 化粧料 |
WO1994010971A1 (en) * | 1992-11-11 | 1994-05-26 | Unilever Plc | Cosmetic composition containing succinic acid esters |
FR2720641B1 (fr) * | 1994-06-03 | 1996-07-26 | Oreal | Compositions cosmétiques antisolaires comprenant de la 2,4,6-tris[p-(2'-éthylhexyl-1'-oxycarbonyl)anilino]-1,3,5-triazine et du malate de dioctyle et utilisations. |
-
1997
- 1997-02-12 JP JP04459697A patent/JP3537622B2/ja not_active Expired - Fee Related
- 1997-02-25 US US08/806,162 patent/US5849272A/en not_active Expired - Lifetime
- 1997-02-25 KR KR1019970006437A patent/KR100472671B1/ko not_active IP Right Cessation
- 1997-02-26 DE DE69723331T patent/DE69723331T2/de not_active Expired - Lifetime
- 1997-02-26 AU AU14932/97A patent/AU706812B2/en not_active Ceased
- 1997-02-26 CN CNB971109397A patent/CN1162144C/zh not_active Expired - Fee Related
- 1997-02-26 EP EP97301266A patent/EP0791353B1/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100393298C (zh) * | 2003-06-24 | 2008-06-11 | 巴斯福股份公司 | 由uv-a和uv-b过滤剂组成的混合物 |
CN102066904B (zh) * | 2008-06-13 | 2015-07-15 | 株式会社资生堂 | 皮肤代替膜、模具以及皮肤外用剂的评价方法 |
CN106999385A (zh) * | 2014-11-10 | 2017-08-01 | 花王株式会社 | 水包油型紫外线防护化妆品 |
CN106999385B (zh) * | 2014-11-10 | 2020-12-29 | 花王株式会社 | 水包油型紫外线防护化妆品 |
Also Published As
Publication number | Publication date |
---|---|
JP3537622B2 (ja) | 2004-06-14 |
EP0791353B1 (en) | 2003-07-09 |
CN1162144C (zh) | 2004-08-18 |
JPH09291019A (ja) | 1997-11-11 |
AU1493297A (en) | 1997-09-04 |
AU706812B2 (en) | 1999-06-24 |
US5849272A (en) | 1998-12-15 |
DE69723331T2 (de) | 2004-05-27 |
DE69723331D1 (de) | 2003-08-14 |
KR19980069385A (ko) | 1998-10-26 |
EP0791353A1 (en) | 1997-08-27 |
KR100472671B1 (ko) | 2005-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1172641A (zh) | 紫外线吸收性组合物 | |
CN1186007C (zh) | 防晒制剂 | |
CN1112910C (zh) | 以脂类泡状物为主要成分的酸性组合物及其局部施敷的应用 | |
CN1047515C (zh) | 口红 | |
CN1784205A (zh) | 脂质组合物及含有该脂质组合物的护肤制剂 | |
CN1106661A (zh) | 表皮用制剂和其制备方法 | |
CN1011287B (zh) | 口腔卫生制剂 | |
CN1158560A (zh) | 可生物降解的季盐类头发和皮肤调理剂 | |
CN1465338A (zh) | 用于外用抗老化制剂的皮肤活化组合物 | |
CN1155240A (zh) | 槐糖类脂物的应用,化妆用组合物和护肤用组合物 | |
CN1665478A (zh) | 囊泡分散物及含有囊泡分散物的化妆品 | |
CN1106660A (zh) | 表皮用制剂和其制备方法 | |
CN1541089A (zh) | 保湿剂以及含有保湿剂的化妆品和外用剂 | |
CN1751570A (zh) | 用于控制微生物的具有储库效应的组合物 | |
CN1504180A (zh) | 油包水乳液化妆组合物 | |
CN1106659A (zh) | 表皮用制剂和其制备方法 | |
CN1100927A (zh) | 化妆笔 | |
CN1867312A (zh) | 紫外线防护制剂及含有紫外线防护制剂的化妆品 | |
CN1535162A (zh) | 皮肤外用剂 | |
CN1081876A (zh) | 增白美容剂 | |
CN1539006A (zh) | 羊毛脂代用品,得到它的方法及其应用 | |
CN1394135A (zh) | 微生物包封的材料在化妆品最终配方中的应用 | |
CN1655800A (zh) | 用于改善黑斑病的组合物以及用于减轻肌肤黯淡的组合物 | |
CN1652741A (zh) | 皮肤外用制剂 | |
CN1875915A (zh) | 一种具有抗水性的个人护理用水包油乳剂组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040818 Termination date: 20130226 |